	Melphalan
Hypoxic
Isolated hepatic perfusion
Retrograde outflow
Metastasis
	operation time
retrograde
bile duct necrosis
perfusion
IHHP
blood loss
extrahepatic disease
Hepatic toxicity
response rates comparable
liver
patients
Tumor response
minute pump infusion
concentration
melphalan concentration
perfusion circuit
partial response
minutes
preclinical study
melphalan
study
median not
IHPP procedure
systemic melphalan concentrations
tumor progression
circuit
progressive disease
response
minute infusion
times the normal values
pharmacokinetics
hepatic artery
stable disease
simple procedure
portal vein
present series
heart-lung machine
survival
progressive
months
treatment
time
leakage
median
hepatic metastases

